| # | Drug | Count |
|---|---|---|
| 0 | OCRELIZUMAB | 71 |
| 1 | HYDROCORTISONE | 28 |
| 2 | RITUXIMAB | 26 |
| 3 | METHYLPREDNISOLONE | 18 |
| 4 | ACETAMINOPHEN | 15 |
| 5 | ALEMTUZUMAB | 15 |
| 6 | LEVOTHYROXINE SODIUM | 15 |
| 7 | DULOXETINE | 13 |
| 8 | DULOXETINE HYDROCHLORIDE | 13 |
| 9 | ACYCLOVIR | 12 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | MEPIVACAINE HYDROCHLORIDE | 3 | 0.0026 |
| 1 | OCRELIZUMAB | 71 | 0.0011 |
| 2 | ALEMTUZUMAB | 15 | 0.0008 |
| 3 | TREOSULFAN | 2 | 0.0007 |
| 4 | VERAPAMIL HYDROCHLORIDE | 2 | 0.0005 |
| 5 | IMIQUIMOD | 1 | 0.0004 |
| 6 | ALBUMIN HUMAN | 2 | 0.0004 |
| 7 | GLOFITAMAB | 1 | 0.0004 |
| 8 | ALBUMIN (HUMAN) | 2 | 0.0004 |
| 9 | TOLTERODINE TARTRATE | 3 | 0.0003 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | CD19-directed Cytolytic Antibody [EPC] | 2 | 0.0023 |
| 1 | Guanylate Cyclase-C Agonist [EPC] | 2 | 0.0010 |
| 2 | CD52-directed Cytolytic Antibody [EPC] | 15 | 0.0008 |
| 3 | Endoglycosidase [EPC] | 1 | 0.0005 |
| 4 | CD38-directed Cytolytic Antibody [EPC] | 2 | 0.0003 |
| 5 | CD20-directed Cytolytic Antibody [EPC] | 102 | 0.0003 |
| 6 | Bispecific CD20-directed CD3 T Cell Engager [EPC] | 1 | 0.0002 |
| 7 | Provitamin D2 Compound [EPC] | 6 | 0.0002 |
| 8 | Human Immunoglobulin G [EPC] | 4 | 0.0002 |
| 9 | beta3-Adrenergic Agonist [EPC] | 9 | 0.0002 |